Weijuan Jia
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Surgery
- Topics
- Breast Cancer Treatment Studies (19 papers)Breast Lesions and Carcinomas (14 papers)HER2/EGFR in Cancer Research (7 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Weijuan Jia
34 papers receiving 989 citations
Peers
Comparison fields: 5 of 83
- Oncology 522
- Cancer Research 439
- Molecular Biology 235
- Pathology and Forensic Medicine 172
- Surgery 140
Countries citing papers authored by Weijuan Jia
This map shows the geographic impact of Weijuan Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijuan Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijuan Jia more than expected).
Fields of papers citing papers by Weijuan Jia
This network shows the impact of papers produced by Weijuan Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijuan Jia. The network helps show where Weijuan Jia may publish in the future.
Co-authorship network of co-authors of Weijuan Jia
This figure shows the co-authorship network connecting the top 25 collaborators of Weijuan Jia. A scholar is included among the top collaborators of Weijuan Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijuan Jia. Weijuan Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 116 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 88 | |
| 7 | 34 | |
| 8 | 16 | |
| 9 | 20 | |
| 10 | 74 | |
| 11 | 14 | |
| 12 | 50 | |
| 13 | 16 | |
| 14 | 20 | |
| 15 | 30 | |
| 16 | 22 | |
| 17 | 61 | |
| 18 | 15 | |
| 19 | 61 | |
| 20 | 56 |
About Weijuan Jia
Weijuan Jia is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (14 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Cancer Research (439 citations), Oncology (522 citations) and Pathology and Forensic Medicine (172 citations). Weijuan Jia has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Fengxi Su, Erwei Song, Shunrong Li, Kai Chen, Fengxi Su, Jiannan Wu, Heran Deng, Yaping Yang, Jieqiong Liu and Chang Gong. Their work appears in journals such as Nature Communications, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.